PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 132 filers reported holding PROTAGONIST THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $11,801,032 | -17.1% | 427,264 | -30.9% | 0.14% | -27.8% |
Q1 2023 | $14,228,145 | +154.6% | 618,615 | +20.8% | 0.19% | +158.7% |
Q4 2022 | $5,587,447 | +81.8% | 512,140 | +31.8% | 0.08% | +59.6% |
Q2 2022 | $3,074,000 | -77.9% | 388,637 | -34.0% | 0.05% | -79.2% |
Q1 2022 | $13,940,000 | -17.3% | 588,694 | +19.4% | 0.23% | -6.6% |
Q4 2021 | $16,860,000 | – | 492,987 | – | 0.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 2,449,183 | $56,331,209 | 18.32% |
Kynam Capital Management, LP | 1,375,000 | $31,625,000 | 4.08% |
BVF INC/IL | 3,775,900 | $86,845,700 | 3.18% |
Cormorant Asset Management, LP | 1,700,000 | $39,100 | 2.58% |
RTW INVESTMENTS, LP | 4,600,799 | $105,818,377 | 2.20% |
Ghost Tree Capital, LLC | 225,000 | $5,175,000 | 1.53% |
683 Capital Management, LLC | 791,000 | $18,193,000 | 1.36% |
Ikarian Capital, LLC | 211,400 | $4,862,200 | 1.10% |
Ikarian Capital, LLC | 211,400 | $4,862,200 | 1.10% |
SILVERARC CAPITAL MANAGEMENT, LLC | 105,486 | $2,426,178 | 1.00% |